Caroline Xie - General Partner @ ICONIQ Capital

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Caroline Xie is the Board of Directors of DexCare.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Causaly	ICONIQ Growth	Yes	Series B - Causaly	obfuscated obfuscation
obfuscated obfuscation	DexCare	ICONIQ Growth	Yes	Series C - DexCare	obfuscated obfuscation
obfuscated obfuscation	Apprentice.io	ICONIQ Growth	Yes	Series C - Apprentice.io	obfuscated obfuscation
obfuscated obfuscation	Nayya	ICONIQ Growth	Yes	Series C - Nayya	obfuscated obfuscation
obfuscated obfuscation	Notable	ICONIQ Growth	Yes	Series B - Notable	obfuscated obfuscation
obfuscated obfuscation	Nayya	ICONIQ Growth	Yes	Series B - Nayya	obfuscated obfuscation
obfuscated obfuscation	Unite Us	ICONIQ Capital	Yes	Series C - Unite Us	obfuscated obfuscation

Number of Current Jobs

is the

General Partner

Number of Current Board & Advisor Roles

is the

Board Member

Hub Name	CB Rank (Hub)
San Francisco Bay Area Private Equity Stage Investors	21,384
San Francisco Bay Area Investors with Funds Raised in 2025	32,484
San Francisco Bay Area Private Equity Firms	19,080
West Coast Grant Investors	63,369
Grant Investors with Investments in United States	20,822
Post IPO Investors with Investments in Western US	28,206
California Investors with Funds Raised in 2013	73,648
San Francisco Bay Area Secondary Market Investors	50,187
Secondary Market Investors with Investments in United States	36,843
Morgan Stanley Alumni Founded Companies	36,011

studied at

There is no recent news or activity for this profile.